Latest Research Updates

Global Leukemia Therapeutics Market Analysis, Growth, Research and Business Forecast 2018-2025

Press Release   •   Apr 03, 2018 03:16 EDT

The Global Leukemia Therapeutics Market is expected to reach $11.2 billion by the end of 2020 growing at a CAGR of around 4.7% from 2014 to 2021. Leukemia is a form of cancer which occurs when there is an excess of abnormal white blood cells in the blood. Under normal conditions, the blood forming cells of the bone marrow produce leukocytes for defense against viruses and bacteria. If the leukocytes are damaged and if they remained untreated they get accumulated in the body. The untreated cells then invade other parts of the body like spleen, liver and central nervous system. The main reasons causing leukemia are smoking, ionizing radiation, prior chemotherapy and Down syndrome.

The symptoms of leukemia include fever, pain in bones, weight loss, shortness of breath, bleeding under the skin, etc. The treatment of leukemia involves radiation therapy, targeted therapy, chemotherapy and bone marrow transplant. The Global Leukemia Therapeutics Market is segmented on the basis of Types (Acute Leukemia, Chronic Leukemia, Acute Myelogenous Leukemia and Chronic Myelogenous Leukemia), Drugs (Tosedosat, Sapacitabine, GA101, Vosaroxin, Revlimid, Omapro, Dacogen, Marqibo, Bosutinib, Graspa and Vidaza) and Region (North America, Europe, Asia Pacific and Rest of the World).

Download Sample Copy Of This Report From Here: www.amecoresearch.com/sample/2084

Drivers

Rise in innovative techniques generating drugs, rise in the incidence of leukemia due to change in lifestyle and largest market with fretting needs are some of the major reasons driving the market growth.

Challenges

High cost of drugs and large number of entry-to-market barriers are some of the challenges faced by the market.

What the report offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Leukemia Therapeutics Market, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Leukemia Therapeutics Market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology

2. Executive Summary

3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Rise in innovative techniques generating drugs
3.2.2 Rise in the incidence of leukemia due to change in lifestyle
3.2.3 Largest market with fretting needs
3.3 Market Restraints
3.3.1 High cost of drugs
3.3.2 Large number of entry-to-market barriers
3.4 Market Opportunitites
3.5 Market Threats

4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants

5. Market Segmentation
5.1 Global Luekmia Therapeutics Market
5.1.1 By Types
5.1.1.1 Acute Leukemia
5.1.1.2 Chronic Leukemia
5.1.1.3 Acute Myelogenous Leukemia
5.1.1.4 Chronic Myelogenous Leukemia
5.1.2 By Drugs
5.1.2.1 Tosedosat
5.1.2.2 Sapacitabine
5.1.2.3 GA101
5.1.2.4 Vosaroxin
5.1.2.5 Revlimid
5.1.2.6 Omapro
5.1.2.7 Dacogen
5.1.2.8 Marqibo
5.1.2.9 Bosutinib
5.1.2.10 Graspa
5.1.2.11 Vidaza
5.1.3 By Geography
5.1.3.1 North America
5.1.3.1.1 USA
5.1.3.1.2 Canada
5.1.3.1.3 Mexico
5.1.3.2 Europe
5.1.3.2.1 UK
5.1.3.2.2 Germany
5.1.3.2.3 France
5.1.3.2.4 Italy
5.1.3.2.5 Spain
5.1.3.3 Asia Pacific
5.1.3.3.1 China
5.1.3.3.2 Japan
5.1.3.3.3 India
5.1.3.3.4 Australia
5.1.3.4 ROW

6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players

7. Company Profiles
7.1 Novartis
7.2 Pfizer
7.3 Bristol-Myers Squibb Company
7.4 Genzyme
7.5 Ambit
7.6 Celgene
7.7 Glaxosmithkline
7.8 Cephalon
7.9 Eisai

Buy Now This Report From Here: www.amecoresearch.com/buy/2084

About Us:

In today's world with ever increasing competition in every business vertical, to succeed in the business, it has become sufficiently important to stand out by implementing certain strategies and gain a competitive edge over competitors. Ameco Research does this for you. We are a global provider of market intelligence service with the alliance with leading market research firms in the world.

Contact us:

Office 201, 2nd Floor,

Vaidhehi Saaket, Deepa Housing Soc,

Baner-Pashan Link Road, Pune

sales@amecoresearch.com

Call: +91 20 65600384